HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 45 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,822,145 | +113.4% | 55,604 | +129.2% | 0.00% | – |
| Q2 2023 | $853,884 | -46.9% | 24,265 | -50.7% | 0.00% | – |
| Q1 2023 | $1,606,837 | -36.6% | 49,214 | +6.9% | 0.00% | – |
| Q4 2022 | $2,535,757 | +27.2% | 46,021 | +2.3% | 0.00% | – |
| Q3 2022 | $1,994,000 | +27.8% | 45,008 | +40.8% | 0.00% | – |
| Q2 2022 | $1,560,000 | +16.2% | 31,964 | +15.7% | 0.00% | – |
| Q1 2022 | $1,343,000 | -14.9% | 27,620 | -25.4% | 0.00% | – |
| Q4 2021 | $1,579,000 | +164.5% | 37,026 | +137.9% | 0.00% | – |
| Q3 2021 | $597,000 | +285.2% | 15,565 | +184.6% | 0.00% | – |
| Q2 2021 | $155,000 | -52.2% | 5,470 | -44.2% | 0.00% | – |
| Q1 2021 | $324,000 | +458.6% | 9,797 | +514.6% | 0.00% | – |
| Q4 2020 | $58,000 | +5700.0% | 1,594 | +4881.2% | 0.00% | – |
| Q3 2020 | $1,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |